Cardiac EP Specialist – LA (Ablation & Devices)

Kaiser Permanente; Los Angeles (CA); On-site; USD 507,000 - 731,000; Full time

Benefits offered by this job

Medical/dental/vision coverage

Supplemental medical coverage

Vacation/holiday/sick/education leave

Retirement and savings plans

Relocation package

Professional liability coverage

PSLF eligible

Job summary

The Southern California Permanente Medical Group (SCPMG) is seeking a Board-certified/Board-eligible Cardiologist EP3 at the Los Angeles location (LAMC) to provide comprehensive cardiac electrophysiology services, including AF ablation and VT management, with potential travel to EP clinics.

Ideal candidates will have expertise in CIED implantation, lead extraction, and a strong interest in teaching, program development, and clinical innovation. Anticipated start date: January 2027.

Qualifications

• Board Certified or Board Eligible in Clinical Cardiac Electrophysiology.
• Location: LAMC with possible travel to outlying EP clinics.
• Scope of practice: Comprehensive cardiac electrophysiology including AF ablation (RF/PFA), VT management and ablation, CIED implantation and management, conduction system pacing, leadless pacing, ICD/CRT implantation, and lead extraction development.

Responsibilities

• Provide comprehensive cardiac electrophysiology services including AF ablation, VT management, and complex arrhythmia care.
• Lead lead extraction development and expansion of VT ablation programs; contribute to teaching, program development, and quality improvement.
• Collaborate with multidisciplinary teams to advance patient care and participate in clinical innovation.

Job description

The Southern California Permanente Medical Group (SCPMG) is seeking a Board-certified/Board-eligible Cardiologist EP3 at the Los Angeles location (LAMC) to provide comprehensive cardiac electrophysiology services, including AF ablation and VT management, with potential travel to EP clinics.

Ideal candidates will have expertise in CIED implantation, lead extraction, and a strong interest in teaching, program development, and clinical innovation. Anticipated start date: January 2027.